Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$21.19 - $40.01 $6.09 Million - $11.5 Million
-287,600 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$30.97 - $54.03 $2.82 Million - $4.91 Million
90,900 Added 46.21%
287,600 $1.58 Million
Q2 2021

Aug 16, 2021

BUY
$38.75 - $51.0 $6.89 Million - $9.06 Million
177,700 Added 935.26%
196,700 $1.31 Million
Q1 2021

May 17, 2021

BUY
$26.34 - $83.07 $500,460 - $1.58 Million
19,000 New
19,000 $221,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $944M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.